The Valley Desk

Clinical trial reportAmerican journal of hematologyPublished

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
American journal of hematology
Published
Subject terms
Humans; Brain Injuries; Cerebral Infarction; Anemia, Sickle Cell; Hydroxyurea; Antisickling Agents; Feasibility Studies; Pilot Projects; Double-Blind Method; Child, Preschool; Infant; Female
PubMed ID
38953438
PubMed Central ID
PMC11502276
Added to directory
Source checked

Report a correction or request removal